Even though it is possible that the follow-up times (6 to 12 months) were not long enough to observe these differences, at least during these periods of follow-up, there was no worsening kidney function among kidney transplant recipients with DM treated with SGLT-2. Here, SLC5A2 is linked to diabetes mellitus.